Photo: Courtney Hale/Getty Images
Over the last decade, digital therapeutics have been gaining steam. In part, this shift is aided by the adoption of connected medical tools during the COVID-19 pandemic and the ongoing push toward more of a hybrid care model. However, the technologies have largely not yet hit the mainstream market. Today, industry players are looking to get stakeholders from the provider, payer and life science industries onboard.
Read the source article at MobiHealthNews